Downloads
Abstract
Background: The ultimate goal in the treatment of a brain arteriovenous malformation (bAVM) is radical treatment that includes eradication of the entire feeding arteries, nidus and draining veins. In patients who are completely treated, not all have good results, there are still serious complications. Therefore, we carry out this study with the following objectives: (1) Investigate clinical and imaging characteristics of patients with bAVM before and after radical endovascular intervention; (2) Evaluate functional outcome after 3 months of treatment.
Methods: A cross - sectional prospective study on 50 patients, including 31 cases with intracranial hemorrhage and 19 cases without bleeding, were treated at the Stroke Center, Hue Central Hospital from January 2019 to June 2022.
Results: Endovascular intervention procedure was performed 83 times to completely embolize bAVM in 50 patients. Serious complications ratio encountered in 1 interventional procedure was 3.6%. For the group of unruptured bAVM, the radical treatment helped nearly two - thirds of patients significantly improve headache, more than half improve epilepsy within 3 months. The procedural complications leading to moderate sequelae (mRS = 3) was 5.3%. In the group of ruptured bAVM, there was no case of re - bleeding within 3 months of follow - up.
Conclusions: Endovascular intervention for radical treatment of brain arteriovenous malformation in patients with indications is safe and effective.
References
Rutledge WC, Ko NU, Lawton MT, Kim H. Hemorrhage
rates and risk factors in the natural history course of brain
arteriovenous malformations. Translational stroke research.
; 5: 538-542.
Tatlisumak T, Cucchiara B, Kuroda S, Kasner SE, Putaala
J. Nontraumatic intracerebral haemorrhage in young adults.
Nature Reviews Neurology. 2018; 14(4): 237-250.
Cuong NN, Đánh giá kết quả điều trị nút mạch dị dạng động
tĩnh mạch não đã vỡ bằng dung dịch kết tủa không ái nước
(phil). 2020, Đại học Y Hà Nội. p. 55-77.
Gross BA, Du R. Natural history of cerebral arteriovenous
malformations: a meta-analysis. Journal of neurosurgery.
; 118(2): 437-443.
Derdeyn CP, Zipfel GJ, Albuquerque FC, Cooke DL, Feldmann
E, Sheehan JP, et al. Management of brain arteriovenous
malformations: a scientific statement for healthcare
professionals from the American Heart Association/American
Stroke Association. Stroke. 2017; 48(8): e200-e224.
Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly
ES, et al. Predictors of hemorrhage in patients with
untreated brain arteriovenous malformation. Neurology.
; 66(9): 1350-1355.
Khanna D, Khanna AK. Epidemiology of Vascular
Malformations. Vascular Malformations. 2021: 11-18.
Catapano JS, Frisoli FA, Nguyen CL, Wilkinson DA,
Majmundar N, Cole TS, et al. Spetzler-Martin grade III
arteriovenous malformations: a multicenter propensityadjusted analysis of the effects of preoperative embolization.
Neurosurgery. 2021; 88(5): 996.
Dumont TM, Kan P, Snyder KV, Hopkins LN, Siddiqui
AH, Levy EI. A proposed grading system for endovascular
treatment of cerebral arteriovenous malformations: Buffalo
score. Surgical neurology international. 2015; 6.
Pulli B, Stapleton CJ, Walcott BP, Koch MJ, Raymond
SB, Leslie-Mazwi TM, et al. Comparison of predictive
grading systems for procedural risk in endovascular
treatment of brain arteriovenous malformations: analysis of
consecutive patients. Journal of Neurosurgery. 2019;
(2): 342-350.
Baharvahdat H, Blanc R, Fahed R, Smajda S, Ciccio G,
Desilles JP, et al. Endovascular treatment for low-grade
(Spetzler - Martin I-II) brain arteriovenous malformations.
American Journal of Neuroradiology. 2019; 40(4): 668-672.
Elsenousi A, Aletich VA, Alaraj A. Neurological outcomes
and cure rates of embolization of brain arteriovenous
malformations with n-butyl cyanoacrylate or Onyx: a metaanalysis. Journal of neurointerventional surgery. 2016;
(3): 265-272.
Pal A, Blanzy J, Gómez KJR, Preul MC, Vernon BL. Liquid
Embolic Agents for Endovascular Embolization: A Review.
Gels. 2023; 9(5): 378.
Josephson CB, Bhattacharya JJ, Counsell CE,
Papanastassiou V, Ritchie V, Roberts R, et al. Seizure
risk with AVM treatment or conservative management:
prospective, population-based study. Neurology. 2012;
(6): 500-507.
Ellis JA, Munne JCM, Lavine SD, Meyers PM, Connolly
Jr ES, Solomon RA. Arteriovenous malformations and
headache. Journal of Clinical Neuroscience. 2016; 23:
-43.
Choi JH, Mast H, Hartmann A, Marshall RS, Pile-Spellman
J, Mohr JP, et al. Clinical and morphological determinants of
focal neurological deficits in patients with unruptured brain
arteriovenous malformation. Journal of the neurological
sciences. 2009; 287(1-2): 126-130.
Choi JH, Mast H, Sciacca RR, Hartmann A, Khaw AV,
Mohr JP, et al. Clinical outcome after first and recurrent
hemorrhage in patients with untreated brain arteriovenous
malformation. Stroke. 2006; 37(5): 1243-1247.
Hartmann A, Mast H, Mohr JP, Koennecke H-C, Osipov A,
Pile-Spellman J, et al. Morbidity of intracranial hemorrhage
in patients with cerebral arteriovenous malformation.
Stroke. 1998; 29(5): 931-934.
Wu EM, El Ahmadieh TY, McDougall CM, Aoun SG, Mehta
N, Neeley OJ, et al. Embolization of brain arteriovenous
malformations with intent to cure: a systematic review.
Journal of neurosurgery. 2019; 132(2): 388-399.
Feldstein E, Zhong A, Clare K, Nolan B, Patel S, LaviRomer N, et al. Ruptured arteriovenous malformation
mortality: Incidence, risk factors, and inpatient
outcome score. Interventional Neuroradiology. 2023:
Luzzi S, Elia A, Del Maestro M, Morotti A, Elbabaa SK,
Cavallini A, et al. Indication, timing, and surgical treatment
of spontaneous intracerebral hemorrhage: systematic
review and proposal of a management algorithm. World
neurosurgery. 2019; 124: e769-e778.
| Published | 28-12-2024 | |
| Fulltext |
|
|
| Language |
|
|
| Issue | No. 89 (2023) | |
| Section | Original article | |
| DOI | 10.38103/jcmhch.89.4 | |
| Keywords | Dị dạng động tĩnh mạch não, AVM não, Nút mạch, Can thiệp mạch não Brain arteriovenous malformation, bAVM, AVM embolization, AVM management. |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2023 Journal of Clinical Medicine Hue Central Hospital